Dr. Gregory Fink received his Ph.D. in pharmacology and toxicology from Tulane University in 1975. He did postdoctoral work at the University of Iowa from 1975-1977, where his research focused on neural control of the circulation in hypertension. Since 1977 Dr. Fink has been in the Department of Pharmacology and Toxicology at Michigan State University where he became a full professor in 1987. His research continues to focus on sympathetic mechanisms of blood pressure regulation in hypertension, but other important interests are the renin-angiotensin system, endothelin and the role of venous function and body fluid volume distribution in control of blood pressure. More recently his work has focused on the causes of obesity-related cardiovascular disease. Throughout his career he has served on the editorial boards of numerous journals that publish cardiovascular science and been an active member of the American Heart Association Council on Hypertension. He just finished serving a two year term as the Chair of the Council.